Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor VII (activated), or FVIIa, is a serine protease that initiates blood coagulation by forming a complex with tissue factor (TF). This complex activates factors IX and X, leading to thrombin generation and fibrin clot formation. Recombinant human FVIIa (rFVIIa) is used therapeutically to treat bleeding episodes in patients with hemophilia and other clotting disorders.
Binds to tissue factor, forming a complex that activates factors IX and X, leading to thrombin generation and clot formation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor VII (Activated) (FVIIa).